Article

Titers of antibodies the receptor-binding domain (RBD) of ancestral SARS-CoV-2 are predictive for levels of neutralizing antibodies to multiple variants

2022-08-29

Abstract excerpt

<title>Abstract</title> <p>Diagnostic assays currently used to monitor the efficacy of COVID-19 vaccines measure levels of antibodies to the receptor-binding domain of ancestral SARS-CoV-2 (RBDwt). However, the predictive value for protection against new variants of concern (VOCs) has not been firmly established. Here, we used bead-based arrays and flow cytometry to measure binding of antibodies to spike proteins...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 35f3863c-8b40-536b-95ba-8136c0f70264
DOI: 10.21203/rs.3.rs-1500697/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Titers of antibodies the receptor-binding domain (RBD) of ancestral SARS-CoV-2 are predictive for levels of neutralizing antibodies to multiple variantsDOI 10.21203/rs.3.rs-1500697/v2Read

Titers of antibodies the receptor-binding domain (RBD) of ancestral SARS-CoV-2 are predictive for levels of neutralizing antibodies to multiple variantsSemantic proximity Read

Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variantsSemantic proximity Read

Altered affinity to ACE2 and reduced Fc functional antibodies to SARS-CoV-2 RBD variantsSemantic proximity Read

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutantsSemantic proximity Read

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants.Semantic proximity Read

Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacitySemantic proximity Read

Bead-assisted SARS-CoV-2 multi-antigen serological test allows effective identification of patientsSemantic proximity Read

Measurement of binding antibodies to SARS-CoV-2 variants elicited by natural infection and COVID-19 vaccines in a sub-Saharan African populationSemantic proximity Read

Massively Multiplexed Affinity Characterization of Therapeutic Antibodies Against SARS-CoV-2 VariantsSemantic proximity Read

Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses.Semantic proximity Read

Use of a Novel Liquid Bead-Array Assay to Determine Correlation between SARS-CoV-2 Binding Antibody Level and COVID-19 Disease SeveritySemantic proximity Read

Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody featuresSemantic proximity Read